Medpace Holdings (MEDP) Net Cash Flow Growth (5y) (2020 - 2026)
Medpace Holdings (MEDP) Net Cash Flow Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Medpace Holdings | 17.20 Bn | 16.70 Bn | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -93.46% |
| Mar 31, 2026 | 22.67% |
| Dec 31, 2025 | 29.66% |
| Sep 30, 2025 | 32.78% |
| Jun 30, 2025 | -76.22% |
| Mar 31, 2025 | -136.73% |
| Dec 31, 2024 | -22.56% |
| Sep 30, 2024 | 19.30% |
| Jun 30, 2024 | 64.64% |
| Mar 31, 2024 | 86.93% |
| Dec 31, 2023 | 155.27% |
| Sep 30, 2023 | 333.32% |
| Jun 30, 2023 | -52.16% |
| Mar 31, 2023 | 42.40% |
| Dec 31, 2022 | -30.58% |
| Sep 30, 2022 | -7.28% |
| Jun 30, 2022 | -112.13% |
| Mar 31, 2022 | -114.32% |
| Dec 31, 2021 | 25.94% |
| Sep 30, 2021 | 133.35% |